3D bioprinting for the construction of drug testing models-development strategies and regulatory concerns
A drug to be successfully launched in the market requires a significant amount of capital, resources and time, where the unsuccessful results in the last stages lead to catastrophic failure for discovering drugs. This is the very reason which calls for the invention of innovative models that can clo...
Saved in:
| Main Authors: | Divya Mallya, Mrunmayi Ashish Gadre, S. Varadharajan, Kirthanashri S. Vasanthan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2025.1457872/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress in 3D bioprinting of skin: Challenges and opportunities
by: Gupta Shaman, et al.
Published: (2025-07-01) -
Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances
by: Ana Catarina Sousa, et al.
Published: (2025-01-01) -
Transformative bioprinting: 4D printing and its role in the evolution of engineering and personalized medicine
by: Vidhi Mathur, et al.
Published: (2025-07-01) -
Systematic review on the application of 3D‐bioprinting technology in orthoregeneration: current achievements and open challenges
by: Rachel L. Pan, et al.
Published: (2022-01-01) -
3D BIOPRINTING IN DENTISTRY: BIBLIOMETRIC ANALYSIS
by: Peter Frantsevich Litvitskiy, et al.
Published: (2024-12-01)